Business
Voyageur Pharmaceuticals Ltd. Announces Resignation of CFO and Appointment of Interim CFO and Shares for Debt Transaction
(TheNewswire) Calgary, Alberta – TheNewswire - August 15 th ...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals Ltd. Announces Resignation of CFO and Appointment of Interim CFO and Shares for Debt Transaction\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, Alberta –\n \n \n TheNewswire -\n \n \n August 15\n \n \n th\n \n \n , 2022\n \n \n :\n \n \n Voyageur Pharmaceuticals Ltd. (TSXV:VM) (\n \n \n OTC\n \n \n :VYYRF) (the \"Company\" or\n\"Voyageur\") has appointed Albert Deslauriers as interim CFO.\nAl held several senior financial positions with the Lafarge Group over\na 34 year career including Vice President of Finance for Lafarge\nCanada. Al has a financial and general management background with\nmajor public corporations including international experience working\nin Paris, France. He has proven leadership skills involving managing,\ndeveloping, and motivating teams to achieve their objectives. With his\nfirst-class analytical, design and problem-solving skills, Al has\nextensive experience in strategic planning and identifying and\nnegotiating vertical integration opportunities.\n \n \n \n \n Ron Love has resigned as CFO, and we thank him for all\nhis work at Voyageur. Ron’s departure did not result from any\ndisagreement regarding the Company's corporate strategy, financial\nstatements, or disclosures. We wish Ron Love all the best with his new\ncareer path.\n \n \n \n \n Brent Willis, CEO of Voyageur stated “we are very\nfortunate to add Albert to our team, during this transitional period.\nAlbert is known for his strategic thinking and understanding of\nbuilding fully integrated business models. Alberts experience will\nhelp guide management as we begin transitioning the company towards\nsales and Frances Creek production. We will take our time to find a\nsuitable new full time CFO, while utilising Alberts broad range of\ncorporate experience”.\n \n \n \n \n Voyageur has agreed to pay existing debts in an amount\nof $36,410 through the issuance of common shares of the Company\n(\"Common Shares\") at a deemed price per share of $0.10 based\non the closing price of the Common Shares at the close of trading on\nAugust 15, 2022 (the \"Share Payments\").\n \n \n \n \n The Share Payments are subject to regulatory approval,\nincluding the approval of the TSX Venture Exchange. The Common Shares\nissued pursuant to the Share Payment...